For how we live.
Stargardt disease, the most common inherited macular dystrophy, has no approved treatment. In the 50-patient TEASE-1 trial, gildeuretinol slowed atrophic lesion growth by a fraction of a millimetre a year.
WHO validated Timor-Leste's elimination of trachoma, the last suspected focus in its South-East Asia Region. A 2025 survey of 4,949 young children found no transmission requiring intervention.
Serious contact-lens eye infections are uncommon in absolute terms, but overnight wear is the single largest modifiable risk factor. The rare cases can scar the cornea and cost vision.
Reviews put patient satisfaction around 95 percent. FDA-collaborative studies also found that a large minority reported new glare, halos or dry eyes afterward — two true findings that must be held together.
WHO validated Egypt as the 27th country to eliminate trachoma as a public health problem. Its programme began in 2002; the disease still blinds or impairs about 1.9 million people elsewhere.